Company news

Supernus Pharmaceuticals, Inc. news in 2026

Supernus Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader

November 2, 2026

Supernus Announces Third Quarter 2026 Financial Results

October 29, 2026

Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign

October 28, 2026

Supernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl)

October 21, 2026

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

October 19, 2026

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

August 31, 2026

Supernus Announces Second Quarter 2026 Financial Results

August 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

August 3, 2026

Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026

July 22, 2026

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

July 14, 2026

Supernus Expands Partnership With MERGE as AI-Powered Agency of Record

June 17, 2026

Supernus Pharmaceuticals to Participate in June Investor Conferences

May 27, 2026

Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

May 6, 2026

Supernus Announces First Quarter 2026 Financial Results

May 5, 2026

Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026

April 22, 2026

Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

Supernus Pharmaceuticals to Participate in March Investor Conferences

February 22, 2026

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026

February 12, 2026

Calls in 2026

Decks in 2026